Tag: World Stroke Day 2024
Prolong Pharmaceuticals gains US FDA fast-track designation for novel stroke therapy
Prolong Pharmaceuticals has announced that its investigational therapy—PEGylated carboxyhemoglobin, bovine (PP-007)—has received a fast-track designation from the US Food and Drug Administration (FDA) for...
New research indicates sustained improvement in US stroke care over 20-year...
New research, published this month in the journal Stroke, has demonstrated the key role quality improvement programmes play in ensuring hospitals can adequately tackle the...
World Stroke Day 2024: UN General Assembly event emphasises need to...
Today, on World Stroke Day (29 October), here is a timely reminder that stroke is the second leading cause of death globally. Despite the...
World Stroke Day 2024: Terumo Neuro and Tulane University advocate stroke...
On World Stroke Day (29 October), Terumo Neuro has announced that it has partnered with Tulane University School of Medicine (New Orleans, USA) and...
World Stroke Day 2024: WSO launches global coalition to drive policy...
Today, on World Stroke Day (29 October), the World Stroke Organization (WSO) has announced the launch of a global coalition aimed at accelerating policy...
Philips and Medtronic partner to help accelerate access to life-saving stroke...
Royal Philips and Medtronic Neurovascular today announced a strategic advocacy partnership that will see the two companies attempt to raise awareness around potential health...
Ten years of MR CLEAN: Stroke thrombectomy’s evolution and ongoing challenges
This year, 25 October marks a full decade since the initial presentation of results from the MR CLEAN randomised controlled trial (RCT), which—along with...
